<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">

<html>
<head>
	
	<meta http-equiv="content-type" content="text/html; charset=windows-1252"/>
	<title></title>
	<meta name="generator" content="LibreOffice 6.4.0.3 (Windows)"/>
	<meta name="author" content="Stephen O'Brin"/>
	<meta name="created" content="2010-10-29T15:46:37"/>
	<meta name="changed" content="2020-02-11T14:18:06.298000000"/>
	<meta name="AppVersion" content="16.0300"/>
	<meta name="Company" content="WebMD"/>
	<meta name="DocSecurity" content="0"/>
	<meta name="HyperlinksChanged" content="false"/>
	<meta name="LinksUpToDate" content="false"/>
	<meta name="ScaleCrop" content="false"/>
	<meta name="ShareDoc" content="false"/>
	
	<style type="text/css">
		body,div,table,thead,tbody,tfoot,tr,th,td,p { font-family:"Calibri"; font-size:x-small }
		a.comment-indicator:hover + comment { background:#ffd; position:absolute; display:block; border:1px solid black; padding:0.5em;  } 
		a.comment-indicator { background:red; display:inline-block; border:1px solid black; width:0.5em; height:0.5em;  } 
		comment { display:none;  } 
	</style>
	
</head>

<body>
<table cellspacing="0" border="0">
	<colgroup width="254"></colgroup>
	<colgroup width="164"></colgroup>
	<colgroup width="692"></colgroup>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:06</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Salve, mi chiamo Quentin Anstee e sono professore </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di Epatologia sperimentale presso la Facolt&agrave; di Scienze Mediche</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:14</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della Newcastle University, nonch&eacute; medico specialista </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:14</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in epatologia presso la Liver Unit del Freeman Hospital</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di Newcastle Upon Tyne, nel Regno Unito. Benvenuti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a questo programma intitolato &quot;Nuovi progressi nella steatosi epatica:</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">impatto dei dati emergenti sulla pratica clinica in Europa&quot;.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Oggi sono in compagnia della professoressa Elisabetta Bugianesi, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che lavora presso la Divisione di Gastroenterologia</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ed Epatologia del Dipartimento di Scienze Mediche </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">dell'Universit&agrave; di Torino e di Vlad Ratziu,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">professore di Epatologia all'Universit&agrave; della Sorbona </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e all'ospedale Piti&eacute;-Salp&ecirc;tri&egrave;re di Parigi, in Francia. Benvenuti.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:54</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Oggi ci occuperemo dello spettro</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:54</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:00:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della steatosi epatica non alcolica. Penso che molti di noi abbiano</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:00:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">familiarit&agrave; con questa patologia. Quando in un fegato normale</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">iniziano ad accumularsi lipidi, si sviluppa una condizione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:08</font></td>
		<td align="left" valign=bottom><font face="Arial">chiamata steatosi epatica non alcolica, nota con l'acronimo NAFLD. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">In alcuni individui, ci&ograve; porta a una forma infiammatoria </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:16</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della malattia, chiamata steatoepatite non alcolica o NASH,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che, se si protrae per un tempo sufficientemente lungo, pu&ograve;, in alcuni soggetti,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">dare origine a tessuto cicatriziale e fibrosi epatica e, talvolta,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">progredire in fibrosi avanzata, cirrosi e, in alcune persone, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:32</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">anche in carcinoma epatocellulare. Man mano che approfondiamo </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:32</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">le nostre conoscenze sulla steatosi epatica, ci rendiamo sempre pi&ugrave; conto </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che si tratta di un processo molto dinamico. In alcuni soggetti </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la progressione &egrave; continua. In altri, invece,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la patologia ha un andamento altalenante</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e ci&ograve; pu&ograve; verificarsi per diversi motivi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Alcuni di questi sono legati a fattori ambientali, mentre altri</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:01:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">dipendono da fattori genetici intrinseci all'individuo. Tuttavia, i principali </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:01:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:00</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">fattori di rischio a cui dobbiamo prestare attenzione nella pratica clinica</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:00</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sono obesit&agrave;, diabete di tipo 2 e insulinoresistenza, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ipertensione e colesterolo alto; nel complesso,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">le caratteristiche della sindrome metabolica. Esistono anche</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">diversi fattori genetici coinvolti in questa patologia.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:18</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Alcuni esempi sono i geni PNPLA3 and TM6SF2,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:18</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:22</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che presentano polimorfismi a singolo nucleotide </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:22</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che sono stati associati a un maggior rischio di progressione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della malattia, a un maggior rischio di cirrosi e, nel caso</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di PNPLA3, anche a un maggior rischio di carcinoma epatico.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:38</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">La prevalenza della steatosi epatica in Europa &egrave; alta</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:38</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e una recente meta-analisi suggerisce che continuer&agrave;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ad aumentare. Attualmente, si stima che circa</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">il 25% della popolazione europea svilupper&agrave; </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">un certo grado di steatosi epatica non alcolica, il che implica </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che la steatosi epatica ha sostituito il consumo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:02:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di alcol e l'epatite virale come causa pi&ugrave; comune di</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:02:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:03</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">epatopatia. Un dato preoccupante &egrave; che non &egrave; limitata</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:03</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">agli adulti, ma &egrave; una malattia che sta interessando </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">anche i bambini; di conseguenza, le persone saranno</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">esposte al rischio di malattia progressiva</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a partire da un'et&agrave; molto pi&ugrave; giovane. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Una delle difficolt&agrave;, tuttavia, &egrave; ottenere dati affidabili</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sulla prevalenza, pertanto gran parte dei dati che abbiamo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">attualmente a disposizione &egrave; stata ricavata dalla conoscenza</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:32</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della prevalenza dell'obesit&agrave; e del diabete. Ad ogni modo, il modello</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:32</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di Markov suggerisce che, nei prossimi 10 anni circa,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la prevalenza continuer&agrave; ad aumentare. Infatti,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:45</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">si prevede che crescer&agrave; di un ulteriore 21%, passando</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:45</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">da 80 milioni di soggetti in tutta Europa a circa 100 milioni</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di soggetti. In questo scenario, non &egrave; solo la prevalenza </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della steatosi che andr&agrave; ad aumentare, ma verosimilmente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:03:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">anche quella della steatoepatite. Naturalmente, ci&ograve; comporta</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:03:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:03</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">implicazioni significative in termini di spesa sanitaria.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:03</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Professor Ratziu, Vlad, puoi dirci qualcosa di pi&ugrave;?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Cosa sappiamo dei possibili costi sanitari</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:10</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">associati alla steatosi epatica?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:10</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Al momento, disponiamo solo di stime, non conosciamo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">i dati reali e questi sono certamente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:22</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">determinati dal tasso di diagnosi e anche dal fatto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:22</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che la diagnosi avvenga precocemente o tardivamente. Pertanto,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:29</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">possiamo basarci soltanto sulle stime ricavate dalla prevalenza di obesit&agrave;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:29</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:32</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e diabete, sulla nostra conoscenza della prevalenza </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:32</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di patologie gravi nell'ambito di tutti i pazienti affetti da NAFLD,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e anche su quelle che sono le nostre pratiche correnti.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Naturalmente, questi dati non sono molto precisi, anche perch&eacute;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">aumenter&agrave; la consapevolezza, gli strumenti diagnostici stanno migliorando, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:47</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:51</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la diagnosi non invasiva contribuir&agrave; allo screening di un maggior numero</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:51</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:04:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di pazienti e, aspetto importante, la nostra pratica clinica andr&agrave; incontro </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:04:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:00</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a grossi cambiamenti grazie alla disponibilit&agrave; di nuovi farmaci.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:00</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:05</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Nel complesso, possiamo dire, come mostrato da uno degli studi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:05</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">presentati qui all'American Liver Meeting,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che in 5 grandi paesi dell'Europa occidentale</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:19</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la spesa sanitaria associata a questi pazienti &egrave; considerevole.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:19</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:22</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Gran parte dei costi sembra imputabile ai casi pi&ugrave; gravi </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:22</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di NAFLD e NASH. In realt&agrave;, &egrave; stato stimato</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che il 95% dei costi riguardano i pazienti con fibrosi o cirrosi avanzate.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Ci&ograve; &egrave; molto preoccupante, perch&eacute; sappiamo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che una volta giunti allo stato cirrotico in molte altre</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">patologie epatiche &egrave; molto costoso prevenire </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">le complicanze ed evitare trattamenti drastici</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">quali il trapianto di fegato. Ci stiamo occupando di</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:47</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:51</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">tutti questi aspetti adesso, tuttavia ci aspettiamo un impatto significativo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:51</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sui sistemi sanitari a causa di questa patologia.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:05:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Va bene, grazie. Questo &egrave; un punto molto importante. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:05:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">C'&egrave; da dire che noi medici tendiamo a dicotomizzare </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:06</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la diagnosi e a inserire i soggetti in categorie specifiche,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:06</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:10</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ovvero steatosi epatica non alcolica ed epatopatia</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:10</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">alcolica. Esistono evidenze emergenti di un effetto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:18</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sinergico tra alcol e obesit&agrave;, secondo te dovremmo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:18</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">iniziare a considerare queste condizioni come lo spettro</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di un'unica patologia. Qual &egrave; la tua opinione Vlad?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Non sono convinto che si possa parlare di uno spettro. Uno spettro potrebbe</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:30</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">presupporre che le vie metaboliche comuni siano identiche,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:30</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:32</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ma di certo ci&ograve; che dobbiamo comprendere &egrave; la coesistenza</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:32</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:35</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">delle due condizioni. Molte persone possono bere occasionalmente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:35</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">o anche regolarmente quantit&agrave; di alcol dannose.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Pertanto le due condizioni possono chiaramente coesistere</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ed &egrave; stato dimostrato che se si &egrave; obesi e si consuma alcol</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">o, viceversa, se si bevono quantit&agrave; elevate di alcol</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e in pi&ugrave; si &egrave; anche obesi o si &egrave; affetti da sindrome metabolica,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:06:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">il danno epatico &egrave; molto pi&ugrave; grave.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:06:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:00</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Questa sorta di additivit&agrave;/sinergia &egrave; stata dimostrata retrospettivamente. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:00</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Ma, aspetto pi&ugrave; interessante, dall'altro lato dello spettro</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">rispetto al consumo nocivo di alcol, anche </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in studi pi&ugrave; ampi basati sulle popolazioni, indipendentemente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">dal consumo di alcol, la presenza di fattori di rischio metabolici</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:19</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">aumenta la probabilit&agrave; di sviluppare eventi a livello epatico.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:19</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Nei pazienti che consumano alcol, anche in modiche quantit&agrave;,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">siano essi diabetici o obesi, la prevalenza di</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">fattori di rischio metabolici aumenta il danno associato </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e con esso il numero di eventi a livello epatico. Pertanto, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">esiste un contributo da parte di entrambi questi elementi. Non &egrave; possibile</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ignorare l'uno o l'altro. Quindi, piuttosto che cercare di comprenderne</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la fisiopatologia o se esista o meno uno spettro,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ritengo che dovremmo fare uno sforzo per cercare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:48</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di quantificare il meglio possibile la quantit&agrave; di alcol</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:48</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:51</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e quindi di stabilire tra noi se modiche quantit&agrave; </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:51</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di alcol sono accettabili o se, piuttosto,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">dobbiamo bandire del tutto il consumo di alcol.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:07:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Ritengo che questa sia ancora una questione irrisolta.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:07:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">S&igrave;, assolutamente. Ci sono alcuni dati emergenti </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">secondo i quali anche una sola unit&agrave; di alcol al giorno, in particolare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nei pazienti con diabete di tipo 2, pu&ograve; essere associata a una maggiore</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">probabilit&agrave; di fibrosi epatica avanzata. Si tratta</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di una questione ancora aperta e ritengo che in futuro</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:16</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">debba essere presa in considerazione da chi lavora in questo campo.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Esistono diverse caratteristiche che costituiscono</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">i principali indicatori di morbilit&agrave; e mortalit&agrave;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:26</font></td>
		<td align="left" valign=bottom><font face="Arial">per quanto riguarda la steatosi epatica. La cirrosi &egrave; uno a cui</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:29</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">noi medici pensiamo spesso. Un altro &egrave; il carcinoma </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:29</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">epatocellulare e, naturalmente, entrambi contribuiscono</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:38</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">alla crescente necessit&agrave; di trapianti di fegato.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:38</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Elisabetta, in riferimento al rischio di carcinoma epatocellulare,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">quali sono i principali fattori coinvolti? Quali sono</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">le probabilit&agrave; di sviluppare un carcinoma epatocellulare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in un quadro di steatosi epatica?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Il carcinoma epatocellulare nell'ambito della NASH &egrave; un tipo particolare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:08:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di carcinoma epatocellulare, nel senso che non &egrave; influenzato</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:08:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">soltanto dalla malattia epatica in quanto tale, in particolar modo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:06</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">dalla cirrosi, dal momento che pu&ograve; anche insorgere nel fegato non cirrotico.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:06</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:10</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Ci&ograve; avviene perch&eacute; alcuni dei componenti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:10</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della sindrome metabolica, in particolare il diabete di tipo 2</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:16</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e l'obesit&agrave;, sono anch'essi correlati al rischio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di carcinoma epatocellulare, per cui esiste un effetto additivo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di cirrosi, obesit&agrave; e diabete di tipo 2; </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">oltre a ci&ograve; potrebbe essere presente un aspetto genetico, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">quello a cui hai accennato, la variante PNPLA3 GG,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che &egrave; associata a un rischio 5 volte maggiore di carcinoma epatocellulare.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">E, se si vuole prendere in considerazione un singolo fattore di rischio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">o, per meglio dire, se si considera un paziente affetto </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">da molto tempo da malattia epatica, da cirrosi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">o da diabete e il paziente presenta alcune varianti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:09:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di PNPLA3, il rischio di carcinoma epatocellulare </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:09:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; davvero molto alto. Ci&ograve; perch&eacute; la malattia stessa</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">aumenta il rischio di 2,5 volte, l'obesit&agrave; aumenta il rischio di 2,5 volte.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Nel caso dell'obesit&agrave;, il rischio dipende anche dalla sua durata, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">perch&eacute; se l'obesit&agrave; inizia dall'infanzia,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">aumenta il rischio di sviluppare un HCC in et&agrave; adulta</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e il carcinoma epatocellulare si svilupper&agrave;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:29</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">pi&ugrave; precocemente rispetto a coloro che diventano obesi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:29</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in et&agrave; adulta. Questo &egrave; un problema particolarmente importante </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nell'ottica dell'aumento della prevalenza dell'obesit&agrave;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">infantile in tutta Europa, ma anche a livello mondiale.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Quindi, &egrave; la durata della condizione di rischio che ha un ruolo importante?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:48</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&Egrave; l'esposizione ai fattori di rischio: uno &egrave; l'obesit&agrave; e un altro</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:48</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; il diabete di tipo 2. In combinazione con il background genetico,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">questo aspetto potrebbe accelerare la progressione ad HCC.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:10:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">E poi magari nel corso della vita si beve un po' pi&ugrave; di alcol</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:10:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">o si contrae un virus, e questi fattori possono certamente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">far aumentare il rischio di carcinoma epatocellulare.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">L'insorgenza di carcinoma epatocellulare </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in un quadro di NASH diventer&agrave; la condizione con il maggior tasso di crescita</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per l'inclusione nelle liste d'attesa per il trapianto di fegato. Ovviamente,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">l'epatite C e l'epatite B continuano a essere le cause principali,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:30</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ma sono in diminuzione, specialmente l'epatite C.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:30</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:35</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Non cos&igrave; rapidamente. Ci vorr&agrave; del tempo prima di assistere al reale</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:35</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">impatto delle nuove terapie. Tuttavia, nei prossimi 20 anni</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">probabilmente il carcinoma epatocellulare nell'ambito della NASH </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">diventer&agrave; un onere notevole se non facciamo qualcosa prima.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">OK. Tenendo conto di questo, Vlad, cosa dovremmo fare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">attualmente riguardo allo screening per l'HCC?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:11:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Dovremmo testare tutti i soggetti con steatosi epatica? Quale potrebbe essere</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:11:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">il nostro approccio? Cosa ne pensi?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Per il momento, ritengo che se si tratta di un singolo paziente si debba</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">agire come meglio si ritiene, ma se si tratta di pi&ugrave; pazienti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:16</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; necessario elaborare delle politiche che siano applicabili</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:19</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e con un buon rapporto costo-beneficio. Penso che l'unica cosa</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:19</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che si possa dire oggi &egrave; che i pazienti cirrotici devono essere sottoposti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a screening per carcinoma epatocellulare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">esattamente come viene fatto per qualsiasi causa di cirrosi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Ma come comportarsi con i non cirrotici? Si tratta di una questione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">molto difficile, perch&eacute; &egrave; chiaro che esistono casi senza cirrosi,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a volte anche senza un quadro di NASH, ma semplicemente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:41</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di steatosi epatica. Tuttavia, tali casi sembrano sufficientemente rari</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:41</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in termini di incidenza da non giustificare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:48</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">uno screening sistematico. Inoltre, il numero di pazienti a rischio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:48</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:51</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; troppo alto. Pertanto, se seguiamo ci&ograve; che i nostri colleghi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:51</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:12:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">hanno indicato nelle linee guida per la pratica clinica,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:12:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">specialmente quelle dell'ESMO per l'HCC, esiste consenso sul fatto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che lo screening sistematico quando l'incidenza annua &egrave; inferiore all'1,5%</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">non &egrave; economicamente conveniente. E chiaramente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; questo il caso dei pazienti con NASH non cirrotici.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:16</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&Egrave; interessante notare che i pazienti cirrotici devono essere</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">monitorati come facciamo regolarmente, ma anche tra i cirrotici</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sembra esistere un'ampia variabilit&agrave; in termini</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di rischio e alcuni cirrotici sono molto pi&ugrave; a rischio di altri.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:30</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Questo &egrave; un aspetto che abbiamo constatato. &Egrave; anche vero</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:30</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che ciascun agente cancerogeno ha la sua potenza e il potere</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">oncogeno pu&ograve; essere diverso tra HPV, aflatossina, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">HCC e NASH. Pertanto, &egrave; ragionevole ritenere</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che ogni patologia possa averne uno diverso. Quindi si sta ancora </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">cercando di identificare, anche tra i pazienti cirrotici,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:47</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:51</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">quelli a maggior rischio. Per il momento, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:51</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ritengo che i cirrotici debbano essere sottoposti a screening ogni 6 mesi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Per gli altri, solo occasionalmente l'ecografia;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:13:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">non pu&ograve; essere fatta alcuna raccomandazione.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:13:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:00</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Va bene, grazie. Dunque, sappiamo che molti pazienti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:00</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:03</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">con steatosi epatica non alcolica non sviluppano</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:03</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">alcun danno diretto a livello epatico. Infatti, l'articolo del 2015</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">del compianto Paul Angulo ha dimostrato che solo circa</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">il 9-10% dei pazienti seguiti longitudinalmente </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:18</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; andato incontro a decesso legato a problemi epatici e che </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:18</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per un numero maggiore di soggetti la causa &egrave; stata di tipo cardiovascolare.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Elisabetta, puoi dirci qualcosa di pi&ugrave; sugli eventi non correlati al fegato</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:30</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e sugli effetti nei pazienti con steatosi epatica?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:30</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Per prima cosa vorrei fare una premessa su questo lavoro,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">poich&eacute; noi abbiamo contribuito alla sua realizzazione. I pazienti </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:41</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">con NAFLD che stavamo seguendo si trovavano</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:41</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in uno stadio precoce di epatopatia. Questi soggetti erano</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sotto sorveglianza, pertanto vi &egrave; un basso tasso di morbilit&agrave; e mortalit&agrave;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">correlate al fegato appunto a causa di queste due premesse. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:14:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Allo stesso tempo, vediamo molti pazienti </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:14:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che non sono sotto sorveglianza e che vengono inviati da noi in situazioni</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:05</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di cirrosi scompensata, una grave complicanza </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:05</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">come il carcinoma epatocellulare. Detto questo, naturalmente,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la patologia cardiovascolare &egrave; la prima causa di decesso</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per questi tipi di pazienti, dal momento che la NAFLD non &egrave; semplicemente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">una malattia epatica. Si tratta di una patologia sistemica, che deriva</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">da una condizione metabolica che a volte colpisce</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:32</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">anche il fegato, ma in genere il maggior rischio </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:32</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per questi pazienti &egrave; di tipo cardiovascolare.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Il corollario &egrave; che la NAFLD e la sindrome metabolica</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">hanno una sorta di rapporto bidirezionale, poich&eacute; la steatosi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">epatica si verifica quando vi &egrave; un maggior flusso di acidi grassi liberi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">verso il fegato a causa, da un lato, dell'insulinoresistenza del tessuto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:15:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">adiposo. Ma dall'altro lato, quando il fegato diventa grasso</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:15:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">aumenta la sua produzione di glucosio,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:05</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">quindi il paziente ha maggiori probabilit&agrave; di sviluppare diabete di tipo 2</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:05</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e il fegato produce anche una maggiore quantit&agrave; di lipidi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Questo meccanismo produce infine un profilo pi&ugrave; aterogenico</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e, in combinazione con la produzione di proteina C-reattiva e PAI-1,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che sono tutti fattori pro-infiammatori, favorisce in definitiva</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:29</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">lo sviluppo della patologia cardiovascolare.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:29</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:32</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Quindi si tratta di una strada a doppio senso, in cui un fattore induce</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:32</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">l'altro e viceversa. &Egrave; cos&igrave; che lo descriveresti?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">S&igrave;, non &egrave; semplicemente una conseguenza della sindrome </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">metabolica, nonostante sia uno dei fattori principali della sindrome metabolica</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">una volta che il fegato diventa grasso, quindi accresce tutte le conseguenze</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">negative della sindrome metabolica, sia il rischio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di sviluppare il diabete di tipo 2 che il rischio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:16:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di sviluppare eventi di tipo cardiovascolare.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:16:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:03</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">OK, grazie. Quindi, esistono diverse difficolt&agrave;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:03</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:06</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">relative alla gestione dei pazienti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:06</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">con steatosi epatica. Prima di tutto, dobbiamo identificare </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">i pazienti che hanno un rischio maggiore di sviluppare la NAFLD.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:16</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Dopodich&eacute;, dobbiamo occuparci della stratificazione del rischio,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:18</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">al fine di identificare i pazienti affetti da steatosi epatica a rischio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:18</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di presentare gli esiti peggiori. E infine </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ci sono naturalmente problemi relativamente a come gestire </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e trattare al meglio questa patologia.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:30</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Una delle cose che mi preoccupa sempre</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:30</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; se siamo realmente efficaci nell'identificare tutti i pazienti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nella popolazione che sono affetti da steatosi epatica.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Da una parte, le previsioni suggeriscono che circa</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">un quarto della popolazione presenti un certo grado di steatosi epatica.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">E tuttavia, quando consideriamo i dati prevenienti dalla pratica clinica reale,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">come ha fatto un recente studio che ha esaminato una popolazione di oltre</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">18 milioni di soggetti adulti registrati in un database di assistenza primaria</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:17:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in quattro paesi europei, si rileva che </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:17:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">solo 137.000 di tali individui erano effettivamente </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:03</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">classificati come affetti da steatosi epatica.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:03</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Si tratta di una grossa discrepanza e probabilmente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ci&ograve; implica che la steatosi epatica non &egrave; cos&igrave; comune</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:16</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">come pensiamo, ma l'altra interpretazione dei dati,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:18</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e ritengo sia quella molto pi&ugrave; probabile, &egrave; che </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:18</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">stiamo sbagliando nel diagnosticare in modo accurato questa condizione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e che non la stiamo classificando correttamente, pertanto non viene rilevata</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nei dati statistici. Sappiamo che i soggetti affetti da diabete</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di tipo 2, ipertensione, obesit&agrave; e sindrome </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">metabolica hanno una probabilit&agrave; molto pi&ugrave; elevata di presentare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">steatosi epatica. Vlad, puoi commentare ulteriormente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">alcuni dei motivi per cui la steatosi epatica</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">potrebbe essere sottostimata?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Penso che esistano dei motivi storici perch&eacute; per</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">lungo tempo la steatosi &egrave; stata considerata una condizione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:18:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">benigna, che accompagna l'obesit&agrave;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:18:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">o il sovrappeso, di cui non era il caso di preoccuparsi. Inoltre,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">penso che il fatto che non sia disponibile un test semplice</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:14</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in grado di predire la malattia sia anch'esso un ostacolo all'identificazione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:14</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di questi pazienti. Naturalmente, esiste l'ecografia, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ma non &egrave; un esame molto sensibile. Il terzo aspetto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; che per moltissimo tempo la storia naturale </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della malattia non era stata ben compresa, pertanto </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">non esisteva il senso di urgenza che abbiamo oggi in base ai dati disponibili,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:35</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ovvero che i soggetti possono progredire allo stadio terminale</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:35</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:38</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di malattia epatica. Per molti anni si &egrave; ritenuto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:38</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:41</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che non si sarebbe verificata mai, o solo in rari casi, la progressione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:41</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:45</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di questa condizione a malattia epatica in stadio terminale. Infine,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:45</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">anche in caso di diagnosi e di stadiazione, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:54</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">non possiamo fare molto di pi&ugrave; di ci&ograve; che stiamo gi&agrave; facendo,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:54</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ossia cercare di implementare misure a livello di alimentazione e stile di vita.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:19:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">In altre parole, il fatto che non esista una terapia specifica</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:19:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">rappresenta anch'esso un ostacolo significativo per coloro</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:05</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che cercano attivamente di rilevare questa patologia.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:05</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Penso che questi possano essere i fattori. Anche per quanto riguarda</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">tutti gli studi che sono stati iniziati, in particolare quello che hai</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">menzionato prima, dipende dal contesto nel quale</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:19</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">vengono condotti. Se si considerano solo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:19</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">i pazienti ricoverati, naturalmente la percentuale</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sar&agrave; notevolmente inferiore al 24% della popolazione.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Se si considera l'assistenza primaria, secondaria e terziaria,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:29</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a seconda del motivo per il quale le persone si recano dal medico,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:29</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:32</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la percentuale potrebbe essere altamente variabile.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:32</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:35</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">OK. Vorrei parlare un po' della stratificazione del rischio,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:35</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che cos'&egrave;, perch&eacute; &egrave; importante</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e come dovrebbe essere fatta. La prima cosa da dire &egrave; che dobbiamo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">iniziare questo processo individuando chi &egrave; a rischio di malattia epatica.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:47</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">E questo ci riporta a ci&ograve; di cui abbiamo parlato</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">circa gli aspetti della sindrome metabolica. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:54</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Maggiore &egrave; il numero di fattori presentati da un individuo,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:54</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:20:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">maggiore sar&agrave; il rischio a cui &egrave; esposto. Dobbiamo inoltre pensare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:20:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ad escludere altre patologie. Attualmente, la diagnosi di steatosi epatica</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">viene fatta per esclusione, quindi &egrave; importante escludere l'epatite virale,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">l'epatite autoimmune, ecc. Questo &egrave; un passaggio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">fondamentale della diagnosi. In terzo luogo, dobbiamo determinare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:14</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la gravit&agrave; della malattia, una volta stabilita la diagnosi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:14</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:19</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Elisabetta, nel contesto dell'assistenza primaria,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:19</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nell'ambito della comunit&agrave;, come stratificheresti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">i soggetti in base al rischio? Esistono metodi non invasivi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che potrebbero essere utilizzati?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Innanzitutto, la stratificazione per la NAFLD</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nella popolazione totale non &egrave; raccomandata nelle linee guida</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per la pratica clinica. &Egrave; raccomandata nella popolazione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ad alto rischio, ovvero nei soggetti affetti da diabete di tipo 2,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:48</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">con sindrome metabolica conclamata, possibilmente dopo i 45 anni.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:48</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Questo &egrave; quanto stabiliscono le linee guida europee. Poi, una volta</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:21:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">eseguito lo screening per la NAFLD, si possono</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:21:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:00</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">identificare i soggetti con NASH, che rappresenta la vera patologia</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:00</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">epatica progressiva, e in particolare &egrave; necessario stratificare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">coloro che sono a rischio di sviluppare fibrosi grave.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Quindi, gran parte dei test epatici non invasivi di cui disponiamo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">al momento sono concepiti per identificare o escludere la fibrosi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">epatica significativa, ovvero F3, F4, pre-cirrosi o</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">cirrosi. Esistono diversi livelli di test </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:29</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">non invasivi che possiamo utilizzare. I medici di medicina generale</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:29</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">o gli specialisti di altri campi come endocrinologi o</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">cardiologi possono utilizzare, per esempio, il punteggio di fibrosi NAFLD,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che si basa su et&agrave;, AST, ALT, conta piastrinica, IMC,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">presenza di alterata glicemia a digiuno, oppure FIB-4,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:47</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">et&agrave;, AST, ATL e conta piastrinica. Questi sono i due punteggi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">maggiormente raccomandati. Esiste anche</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:22:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">un secondo livello di test, come ad esempio il test ELF,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:22:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che combina componenti del rimodellamento</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">del collagene che si verifica nel corso della fibrosi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:12</font></td>
		<td align="left" valign=bottom><font face="Arial">Un buon esempio di screening nell'ambito dell'assistenza primaria &egrave; il Camden</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:16</font></td>
		<td align="left" valign=bottom><font face="Arial">and Islington NAFLD Pathway, che &egrave; stato condotto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nel Regno Unito. Tutti i medici di medicina generale sono stati invitati</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a sottoporre a screening i propri pazienti con steatosi epatica all'ecografia,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ALT elevata dopo esclusione del consumo di alcol,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:30</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">consumo di alcol significativo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:30</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e altre cause di malattia epatica cronica.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:38</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Il primo tipo di screening &egrave; stato effettuato in base al FIB-4. Il FIB-4</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:38</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:41</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">definisce due soglie, una inferiore e una superiore. Se i pazienti ricadevano</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:41</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">al di sotto della soglia inferiore, non venivano inviati</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">da un epatologo. Se ricadevano al di sopra della soglia superiore,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">venivano inviati da un epatologo a causa</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">del maggior rischio di fibrosi epatica significativa.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:23:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Il problema di tutti questi test non invasivi &egrave; che </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:23:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">presentano una zona grigia, una zona non definita. Pertanto, questa parte</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di pazienti che ricadeva nella zona grigia veniva sottoposta a</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">un test di secondo livello, ovvero il test ELF e, ancora una volta,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ristratificata in base al rischio di fibrosi significativa.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:19</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Questo metodo si &egrave; dimostrato efficace, poich&eacute; il numero di pazienti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:19</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">con fibrosi grave inviati dallo specialista &egrave; passato dall'8%</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">al 30%, mentre la percentuale dei pazienti cirrotici &egrave; passata dal 6% al 14%.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Va bene. Ritengo che uno degli aspetti fondamentali</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di questi test non invasivi &egrave; che hanno tutti un elevato</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:41</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">valore predittivo negativo. Ovvero, sono molto efficaci nell'escludere </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:41</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:45</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la malattia avanzata, ma sono meno efficaci quando si tratta di includerla.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:45</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Quindi, anche in questo esempio, si &egrave; avuto un grande miglioramento per quanto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">riguarda le pratiche di invio allo specialista per la malattia avanzata,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">tuttavia, il 70% dei soggetti inviati non presentava</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:24:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">patologia avanzata. Quindi &egrave; un'area in cui c'&egrave; ancora molto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:24:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">lavoro da fare, ma il messaggio fondamentale &egrave; che si pu&ograve;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">perdere molto tempo a cercare di capire quale sia il test</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">corretto da effettuare. Io ritengo che vada bene qualsiasi test,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">purch&eacute; effettuato in maniera coerente. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Meglio di niente, dal momento che prima lo standard di cura era</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&quot;invia chiunque, non inviare nessuno o invia a caso&quot;.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:16</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Certo, assolutamente.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Anche al di l&agrave; di questo, penso che il messaggio pi&ugrave; importante </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:22</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">da trasmettere al pubblico generale e ai medici</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:22</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di medicina generale &egrave; che, anche prima di effettuare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:29</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">un determinato test, &egrave; necessario riconoscere </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:29</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:32</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che la presenza di fattori di rischio metabolici pone il fegato</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:32</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a rischio. Dopodich&eacute;, bisogna chiedersi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">se il paziente &egrave; sovrappeso o diabetico o soffre </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di dislipidemia o ipertensione o presenta un'associazione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:45</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di queste condizioni; in tal caso, occorre controllare il fegato.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:45</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">A quel punto, si &egrave; liberi di effettuare il test di cui ci si fida.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:47</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Quando un paziente viene identificato nell'ambito dell'assistenza primaria</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:54</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e inviato da te, Vlad, come procedi per la valutazione?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:54</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Tutti i pazienti devono essere sottoposti a biopsia epatica</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:25:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">o possiamo lavorare in modo pi&ugrave; consapevole?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:25:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">S&igrave;, in pratica ci&ograve; che si cerca di fare &egrave; di capire </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:05</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">se il paziente &egrave; a rischio di progressione verso la cirrosi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:05</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Tale rischio viene principalmente calcolato in base allo stadio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della fibrosi, ma anche all'attivit&agrave; della malattia. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Talvolta &egrave; sufficiente valutare lo stadio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della fibrosi, altre volte &egrave; necessario spingersi leggermente oltre</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e cercare anche di comprendere se la NASH stessa</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sia molto attiva o meno. La prima cosa, naturalmente,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; accertarsi che non esistano altre malattie croniche</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e questo ci riporta al problema dell'alcol.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&Egrave; indispensabile capire bene </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">se il consumo di alcol metta il paziente </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:41</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">maggiormente a rischio rispetto a quanto </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:41</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">non sia gi&agrave; a causa della sindrome metabolica.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Il secondo punto &egrave; quello di cercare di ottenere una stima non invasiva</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:47</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:51</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">del grado di fibrosi. Si utilizzano diversi test,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:51</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:54</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che sono pi&ugrave; specialistici, non sono quelli che abbiamo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:54</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:26:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">menzionato in precedenza, sono pi&ugrave; specifici.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:26:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:00</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Il problema &egrave; che non basta un singolo test, quindi idealmente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:00</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">bisognerebbe combinare almeno due test che siano</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:05</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di natura diversa con biomarker biofisici come la</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:05</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">rigidit&agrave; epatica. A questo punto, il problema diventa l'interpretazione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">dei risultati. A volte sono chiarissimi, a volte </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; necessario capire perch&eacute; esistono delle discordanze o meno.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:22</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Una volta fatto questo, in base al profilo del paziente,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:22</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">potrebbe essere il caso di aspettare un po' di tempo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per vedere se il paziente &egrave; in grado di implementare le modifiche della dieta</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e dello stile di vita e verificare se queste misure hanno successo.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Alcuni soggetti giovani che non hanno la malattia in stadio avanzato</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:35</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">potrebbero non sapere affatto di esserne affetti. Potrebbero poi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:35</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:38</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ritornare dopo 4 o 6 mesi e aver gi&agrave; iniziato</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:38</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:41</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a perdere peso e a presentare un miglioramento di alcuni di questi parametri.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:41</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">In tal caso, la biopsia epatica non &egrave; necessaria. Viceversa, soggetti malati</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">da molti anni potrebbero aver gi&agrave; tentato di ottenere questi risultati</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:47</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:51</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">molte volte senza riuscirci. A questo punto, bisogna</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:51</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:54</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">chiedersi se la biopsia potrebbe aiutare a comprendere</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:54</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:27:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">meglio il rischio. Aiuta il paziente a essere maggiormente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:27:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">consapevole delle conseguenze se non introduce qualche cambiamento?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:05</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Inoltre, aiuta il paziente a usufruire di</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:05</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:07</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">questi nuovi farmaci che sono attualmente in via di sviluppo?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:07</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:10</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&Egrave; in questi casi che si esegue una biopsia epatica. Naturalmente,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:10</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">quando si decide di procedere con la biopsia, occorre prendere in considerazione</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:16</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">et&agrave;, comorbilit&agrave; e trattamenti che potrebbero introdurre dei rischi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:16</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nella procedura. &Egrave; una questione molto complessa</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e inoltre bisogna convincere il paziente a</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sottoporsi a questa procedura, che pu&ograve; essere dolorosa.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">OK, grazie. Naturalmente ci sono diversi nuovi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">biomarker in via di sviluppo. Vari di noi qui a questo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">tavolo sono coinvolti in questo processo, per esempio nel consorzio LITMUS,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sostenuto dall'UE, che sta sviluppando e validando nuovi biomarker.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Esiste anche una gamma di strumenti, come il procollagene C3</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:48</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">o l'elastografia a risonanza magnetica. Al momento sono</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:48</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">pi&ugrave; che altro strumenti di ricerca, soprattutto nell'ambito degli studi clinici.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Sar&agrave; comunque interessante verificare se sono efficaci</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:28:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e se possono essere utili nella pratica clinica di routine.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:28:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">In definitiva, al momento, non esiste alcun esame</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:06</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">valido non invasivo per diagnosticare specificamente la steatoepatite.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:06</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Siamo in grado di identificare efficacemente la fibrosi avanzata,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:11</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">possiamo identificare bene la steatosi, ma la biopsia ha ancora</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:11</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la sua utilit&agrave; e in tal caso si tratta di come</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:18</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">eseguirla al meglio. A mio avviso, la tua spiegazione </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:18</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; assolutamente ragionevole.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Attualmente non esistono farmaci approvati per il trattamento della steatosi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">epatica, ma ci&ograve; non significa che non abbiamo opzioni a disposizione.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Gli interventi sullo stile di vita sono fondamentali in questi casi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Dobbiamo collaborare con i nostri pazienti per aiutarli a seguire</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">una dieta e a compiere esercizio fisico per perdere peso,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e valide evidenze indicano che il calo ponderale pu&ograve; migliorare l'aspetto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">istologico dei pazienti con steatosi epatica. La cosa fondamentale, e va tenuto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:45</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">presente ci&ograve; che abbiamo gi&agrave; detto sul rischio cardiovascolare, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:45</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; che &egrave; assolutamente cruciale migliorare il profilo di rischio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">cardiovascolare dei nostri pazienti diabetici, per ottenere</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:29:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">un buon controllo del diabete e nel contempo trattare efficacemente </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:29:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:00</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la dislipidemia. Sono ancora molte le questioni da chiarire</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:00</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in relazione a quale sia il modo pi&ugrave; efficace per ottenere</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">un calo ponderale. Elisabetta, potresti brevemente darci</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:10</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">qualche informazione su cosa consigliare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:10</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ai pazienti e quali sono gli obiettivi da perseguire</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:14</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per quanto riguarda la perdita di peso?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:14</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:19</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Sono molte le diete che possono essere seguite,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:19</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:22</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ma quella che &egrave; risultata maggiormente efficace, in particolare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:22</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:26</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per quanto riguarda il rischio cardiovascolare, &egrave; la dieta mediterranea.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:26</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:30</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Sfortunatamente, abbiamo perso il concetto di dieta mediterranea,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:30</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che non &egrave; costituita solo da pizza e gelato, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ma &egrave; una dieta molto pi&ugrave; complessa, ricca di alimenti di origine vegetale.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Il 40% delle calorie proviene da carboidrati complessi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:48</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Prevede una piccola quantit&agrave; di carne rossa, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:48</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">una maggiore quantit&agrave; di carne bianca e un basso apporto di sale e fruttosio.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:30:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">L'unico fruttosio presente nella dieta mediterranea proviene</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:30:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:01</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">dalla frutta. Il fruttosio &egrave; certamente uno degli elementi </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:01</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">pi&ugrave; nocivi che viene ingerito soprattutto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">da adolescenti e bambini e che si trova nelle bibite, nei cibi industriali,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:18</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nel pane di produzione industriale e cos&igrave; via. In definitiva, per&ograve;, ci&ograve; che</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:18</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:22</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">importa realmente &egrave; la percentuale di calo ponderale che si pu&ograve; ottenere.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:22</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Quindi cerchiamo in qualche modo di personalizzare la dieta</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in base al paziente. La dieta che funziona meglio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; quella pi&ugrave; conveniente, perch&eacute; il paziente pu&ograve;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:41</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">seguirla a lungo. Naturalmente, anche l'attivit&agrave; fisica </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:41</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:45</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; molto importante, perch&eacute; durante la dieta si perdono grassi,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:45</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ma anche massa muscolare, mentre, se si svolge attivit&agrave; fisica,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">si perdono solo grassi preservando i muscoli.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:31:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Inoltre, il rischio di riacquistare il peso perso quando si interrompe la dieta </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:31:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; minore rispetto a coloro che seguono solo la dieta. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:06</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Pensando agli agenti farmacologici,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:06</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">al di l&agrave; delle modifiche dello stile di vita, una delle cose</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che spesso preoccupa, in particolare quando si ha a che fare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:14</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">con un soggetto con diagnosi di malattia epatica,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:14</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">probabilmente con valori epatici alterati,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:22</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">livelli di ALT e AST elevati, &egrave; iniziare in sicurezza.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:22</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Questo &egrave; un punto estremamente importante,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:29</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">perch&eacute; vedo che i nostri pazienti affetti da NAFLD</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:29</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sono sottotrattati rispetto al rischio cardiovascolare,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in particolare i pazienti diabetici, ma le statine sono sicure.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Si dice che le statine producono fumo, non fuoco. Intendo dire</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:49</font></td>
		<td align="left" valign=top><font face="Arial" color="#000000">che le reazioni con esiti funesti sono davvero molto basse. L'aumento di AST</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e ALT che si pu&ograve; osservare durante il primo mese</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:56</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di impiego delle statine non &egrave; un indice di malattia epatica;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:56</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:32:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">in genere i valori si abbassano spontaneamente dopo al massimo 6 mesi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:32:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:04</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">dell'avvio della terapia con statine. Generalmente, consigliamo di ridurre</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:04</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:13</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">gradualmente il dosaggio delle statine in caso di aumento dei livelli di AST o</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:13</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:18</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ALT di oltre 2,5 volte rispetto a quelli basali. Comunque, se non si impiegano </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:18</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">le statine, si pu&ograve; far ricorso all'ezetimibe o ad altri farmaci.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Quindi, abbiamo diverse opzioni con i farmaci esistenti.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Questo &egrave; importante. Attualmente nella pipeline di sviluppo, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Vlad, sono in fase di sperimentazione molti bersagli terapeutici,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ti pregherei di farci una breve panoramica in proposito.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:39</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Cosa abbiamo nella pipeline in termini di fase 3?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:39</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:42</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Attualmente abbiamo diversi farmaci in fase 3 avanzata.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:42</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Per uno di questi sono gi&agrave; stati riportati i risultati</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:47</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di fase 3 e si tratta dell'acido obeticolico. Poi abbiamo </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">elafibranor che, a differenza dell'acido obeticolico che &egrave; un agonista di FXR,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:33:59</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&egrave; un duplice agonista di PPAR, e i risultati</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:33:59</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">saranno presentati molto presto. Abbiamo poi altri tre studi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:06</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di fase 3 attualmente in corso, si tratta di ampi studi globali di fase 3, </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:06</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">internazionali, con oltre 2000 pazienti.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:14</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Uno di questi sta valutando resmetirom,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:14</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">un farmaco tiromimetico. Un altro sta valutando aramchol,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">una molecola ibrida tra un acido biliare e un lipide.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Il terzo sta valutando cenicriviroc,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che &egrave; un antagonista del recettore chemochinico CCR2/CCR5.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Questi vari agenti quindi sono diretti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:37</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">contro diversi aspetti della malattia e la maggior parte di essi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:37</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ha una certa azione metabolica e una certa azione antinfiammatoria.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:45</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">E ne esistono altri che hanno un'azione pi&ugrave; antifibrotica,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:45</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">come cenicriviroc. Per questi, sar&agrave; estremamente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">interessante conoscere l'efficacia e avremo i risultati a breve.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&Egrave; molto importante che tutti prendano parte</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:34:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a questi studi e che convinciamo i pazienti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:34:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:05</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che possono offrire un vantaggio e un contributo significativo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:05</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:09</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">alla ricerca se decidono di prendere parte a questi studi</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:09</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e che non vengono trattati come cavie,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:14</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ma contribuiscono semplicemente al progresso generale della medicina.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:14</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Certo, e, come dici tu, questo &egrave; un periodo</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:20</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">molto interessante. Uno di questi studi &egrave; gi&agrave; stato presentato</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:20</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:23</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e ha fornito risultati positivi. Nello studio REGENERATE</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:23</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sull'acido obeticolico vi erano 2 endpoint primari.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:30</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Uno era associato alla risoluzione della NASH,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:30</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:33</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che purtroppo non &egrave; stato raggiunto. Tuttavia, aspetto importante,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:33</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sono stati ottenuti dati circa l'altro endpoint primario,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nell'analisi intention-to-treat, che hanno dimostrato un miglioramento</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di almeno uno stadio della fibrosi senza peggioramento</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">della steatoepatite nei pazienti trattati affetti da NASH.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:49</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Stiamo iniziando a vedere che in questa patologia</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:49</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:53</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">le terapie farmacologiche saranno di beneficio.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:53</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Si tratta solo di vedere quali di queste</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:35:57</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">saranno approvate.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:35:57</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:00</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">S&igrave;. Ci&ograve; che &egrave; importante capire &egrave; che </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:00</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:02</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">questi due esiti a cui hai accennato sono probabilmente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:02</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:06</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">legati alla progressione della malattia. Ora &egrave; importante</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:06</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:10</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">che alcuni di questi sono stati controllati</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:10</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">nel breve periodo. Sar&agrave; importante verificare</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">se ci&ograve; si tradurr&agrave; in una riduzione dello sviluppo di cirrosi.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:17</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Quindi &egrave; importante che questi studi vengano portati a termine.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:17</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Assolutamente. Dimmi, ci troviamo in una situazione in cui</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:25</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">forse l'anno prossimo saranno disponibili dei farmaci approvati</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:25</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:28</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per la steatosi epatica. In che modo ci&ograve; cambier&agrave; la tua pratica clinica?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:28</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Cambier&agrave; soprattutto rispetto all'invio dallo specialista, perch&eacute; attualmente</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">i medici di medicina generale non inviano i pazienti,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:38</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">anche perch&eacute; non esistono trattamenti specifici.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:38</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:40</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Quindi dicono: &quot;Perch&eacute; dovrei inviare il paziente a un epatologo?</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:40</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:43</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Cosa potrebbe fare di diverso da ci&ograve; che facciamo noi?&quot;</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:43</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Questa situazione cambier&agrave;.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:45</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Assolutamente.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:45</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:46</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">S&igrave;, cambier&agrave;.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:46</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:50</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Per concludere, al momento </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:50</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:52</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">la steatosi epatica &egrave; una condizione ad alta prevalenza.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:52</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:55</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Sappiamo che pu&ograve; avere conseguenze importanti a livello epatico</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:55</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:36:58</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e a livello cardiovascolare, pertanto il nostro compito in quanto</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:36:58</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:03</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">epatologi &egrave; quello di affrontare tutti questi problemi. Dobbiamo intervenire</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:03</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:06</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sulla causa trattando l'obesit&agrave;. Dobbiamo intervenire</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:06</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:08</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sul rischio cardiovascolare trattando la dislipidemia</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:08</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:12</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e il diabete. Dobbiamo stratificare i pazienti in base al rischio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:12</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:15</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e concentrare le cure su quelli che sono a maggior rischio</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:15</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:18</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">di esiti negativi. Disponiamo gi&agrave; di alcuni concetti terapeutici di base,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:18</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:21</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">ma ritengo che uno degli aspetti pi&ugrave; entusiasmanti</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:21</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:24</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">sia senza dubbio che nei prossimi anni il nostro arsenale</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:24</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:27</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">si arricchir&agrave; di ulteriori terapie.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:27</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:31</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">&Egrave; un ottimo periodo per occuparsi di steatosi epatica. </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:31</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:34</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Detto questo, desidero concludere e ringraziare te,</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:34</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:36</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Elisabetta e te, Vlad, per aver partecipato a questa attivit&agrave;.</font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:36</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:41</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">Inoltre, grazie anche a voi per la partecipazione e </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:41</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:44</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">per esservi uniti a noi in questa attivit&agrave;. Vi invito </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:44</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:45</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">a proseguire rispondendo alle domande che seguiranno </font></td>
	</tr>
	<tr>
		<td height="23" align="left" valign=top sdnum="1033;0;0.00"><font face="Arial" color="#000000">00:37:45</font></td>
		<td align="left" valign=top sdnum="1033;0;@"><font face="Arial" color="#000000">00:37:47</font></td>
		<td align="left" valign=bottom><font face="Arial" color="#000000">e a completate la valutazione.</font></td>
	</tr>
</table>
<!-- ************************************************************************** -->
</body>

</html>
